154.16
4.52 (3.02%)
| Penutupan Terdahulu | 149.64 |
| Buka | 151.01 |
| Jumlah Dagangan | 219,648 |
| Purata Dagangan (3B) | 237,465 |
| Modal Pasaran | 3,805,695,488 |
| Harga / Pendapatan (P/E Ke hadapan) | 18.28 |
| Harga / Jualan (P/S) | 1.54 |
| Harga / Buku (P/B) | 1.68 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 19 Feb 2026 |
| Margin Keuntungan | -3.87% |
| Margin Operasi (TTM) | 4.89% |
| EPS Cair (TTM) | -3.83 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 6.70% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 80.57% |
| Nisbah Semasa (MRQ) | 2.59 |
| Aliran Tunai Operasi (OCF TTM) | 209.57 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 77.29 M |
| Pulangan Atas Aset (ROA TTM) | 1.79% |
| Pulangan Atas Ekuiti (ROE TTM) | -4.62% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Instruments & Supplies (US) | Bercampur | Menurun |
| Medical Instruments & Supplies (Global) | Bercampur | Menurun | |
| Stok | ICU Medical, Inc. | Menaik | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | 2.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -4.5 |
| Purata Bergerak Teknikal | -2.5 |
| Osilator Teknikal | -0.5 |
| Purata | -1.38 |
|
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically. |
|
| Sektor | Healthcare |
| Industri | Medical Instruments & Supplies |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 3.04% |
| % Dimiliki oleh Institusi | 101.86% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 180.00 (Keybanc, 16.76%) | Beli |
| Median | 179.00 (16.11%) | |
| Rendah | 178.00 (Piper Sandler, 15.46%) | Beli |
| Purata | 179.00 (16.11%) | |
| Jumlah | 2 Beli | |
| Harga Purata @ Panggilan | 151.63 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Keybanc | 20 Feb 2026 | 180.00 (16.76%) | Beli | 151.63 |
| Piper Sandler | 20 Feb 2026 | 178.00 (15.46%) | Beli | 151.63 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 05 Feb 2026 | Pengumuman | ICU Medical Announces Time of Fourth Quarter 2025 Earnings Conference Call |
| 31 Dec 2025 | Pengumuman | ICU Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |